Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77ee80fc15abd629c420d0bf068d0e06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aba919a772df92cccc656ce434ce0660 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 |
filingDate |
2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962fa9cade9304d3596123b847114631 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c53f602c81d1dd1255636f6bbcbde0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d1a360f18289a6ae7a69a84f926578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd6f5b17d4ddd68b1e64ad6788535e08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cda0770b4abbb7a37327bb8168abfc78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fbb37f8f3f9b6dbdfa9c07adf89cd2d |
publicationDate |
2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021253746-A1 |
titleOfInvention |
Use of dalbavancin in preparation of medicament for inhibiting binding of sars-cov-2 to ace2 |
abstract |
Disclosed is use of Dalbavancin in the preparation of a medicament for inhibiting the binding of SARS-CoV-2 to ACE2, which belongs to the technical field of medicaments. Provided is pharmaceutical preparation use of Dalbavancin in resisting the activity of novel coronavirus by inhibiting the binding of SARS-CoV-2 to ACE2. Dalbavancin can be used in the preparation of a medicament for treating or preventing novel coronavirus pneumonia. |
priorityDate |
2020-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |